Menstrual Blood-Derived Mesenchymal Stem Cells Improve Endometrial Receptivity in a Mouse Model of Embryonic Implantation Dysfunction
Cellular Reprogramming · 2025
DOI: 10.1089/cell.2024.0071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Reprogramming, 2025. Verfasst von Chao Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Key Laboratory of Reproductive Health, Liaoning Research Institute of Eugenics, Reproductive Hospital of China Medical University, Shenyang,…. Hauptthemen laut MEDLINE: Embryo Implantation, Mesenchymal Stem Cells, Endometrium, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liaoning Key Laboratory of Reproductive Health, Liaoning Research Institute of Eugenics, Reproductive Hospital of China Medical University, Shenyang, P.R. China.
ORCID-Profile: Chao Ma
Zitieren
APA
Ma, C., Yi, Y., & Guan, C. (2025). Menstrual Blood-Derived Mesenchymal Stem Cells Improve Endometrial Receptivity in a Mouse Model of Embryonic Implantation Dysfunction. Cellular Reprogramming. https://doi.org/10.1089/cell.2024.0071
Vancouver
Ma C, Yi Y, Guan C. Menstrual Blood-Derived Mesenchymal Stem Cells Improve Endometrial Receptivity in a Mouse Model of Embryonic Implantation Dysfunction. Cellular Reprogramming. 2025. doi:10.1089/cell.2024.0071
BibTeX
@article{Ma2025,
author = {Ma, Chao and Yi, Yue and Guan, Changji},
title = {Menstrual Blood-Derived Mesenchymal Stem Cells Improve Endometrial Receptivity in a Mouse Model of Embryonic Implantation Dysfunction},
journal = {Cellular Reprogramming},
year = {2025},
doi = {10.1089/cell.2024.0071}
}
EUVIMED